Adaptive Biotechnologies (ADPT) Amortization - Intangibles (2018 - 2026)

Adaptive Biotechnologies has disclosed Amortization - Intangibles across 9 years of filings, most recently posting $423000.0 for Q2 2026.

• In Q2 2026, Amortization - Intangibles changed 0.0% year-over-year to $423000.0; the TTM figure through Jun 2026 stood at $1.7 million (changed 0.06% YoY), while the FY2025 annual figure was $1.7 million, changed 0.23% from the prior year.
• Amortization - Intangibles came in at $423000.0 for Q2 2026 at Adaptive Biotechnologies, up from $419000.0 in the prior quarter.
• In the past five years, Amortization - Intangibles ranged from a high of $429000.0 in Q4 2022 to a low of $419000.0 in Q1 2022.
• Average Amortization - Intangibles over 5 years is $424555.6, with a median of $423500.0 recorded in 2022.
• Year-over-year, Amortization - Intangibles advanced 0.95% in 2024 and fell 0.95% in 2025.
• Over 5 years, Amortization - Intangibles stood at $429000.0 in 2022, then changed by 0.0% to $429000.0 in 2023, then fell by 0.23% to $428000.0 in 2024, then advanced by 0.23% to $429000.0 in 2025, then decreased by 1.4% to $423000.0 in 2026.
• Per Business Quant data, the three most recent Amortization - Intangibles figures were $423000.0 in Q2 2026, $419000.0 in Q1 2026, and $429000.0 in Q4 2025.